ADVIA CENTAUR INTACT PARATHYROID HORMONE (IPTH) ASSAY— 510(k) K133601

Name: FDA 510(k) clearance K133601
Creator: U.S. Food and Drug Administration
Published: 2014-02-05

Substantially Equivalent

Siemens Healthcare Diagnostics, Inc.

FDA 510(k) clearance K133601 for ADVIA CENTAUR INTACT PARATHYROID HORMONE (IPTH) ASSAY, Substantially Equivalent on 2014-02-05. Applicant: Siemens Healthcare Diagnostics, Inc.. Device class: 2.

Clearance details

Applicant: Siemens Healthcare Diagnostics, Inc.
Product code: Code CEW
Device class: Class 2
Regulation: 21 CFR 862.1545
Advisory panel: Clinical Chemistry
Date received: 2013-11-25
Decision date: 2014-02-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CEW

view all

K231927 — Elecsys PTH , Elecsys PTH STAT2024-03-22
K232791 — Access Intact PTH2024-03-01
K221197 — VITROS Immunodiagnostic Products Intact PTH II Reagent Pack2023-09-05
K190702 — Lumipulse G whole PTH2019-08-30
K163658 — ADVIA Centaur Intact Parathyroid Hormone (PTH) Assay2017-05-23

More clearances from Siemens Healthcare Diagnostics, Inc.

view all

K253528 — Atellica IM CA 19-9 II2026-08-10
K261364 — Atellica CH Acetaminophen 2 (ACTM)2026-07-24
K251998 — Atellica CH Diazo Total Bilirubin (D_TBil)2026-02-27
K251543 — Atellica® IM TSH3-Ultra II (TSH3ULII)2026-02-06
K251630 — Atellica IM Total PSA II (tPSAII)2026-01-05

Adverse events under product code CEW

product code CEW

Malfunction: 480
Total: 480

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.